Intellectual property organizations

International Trademark Association Releases Updated Guide to Address the Sale of Counterfeits Online

Retrieved on: 
Tuesday, June 8, 2021
Intangible assets, Product management, Intellectual property organizations, International Trademark Association, Marketing, Intellectual property law, Brand management, Articles, INTA, Trademark, Business, Counterfeit

NEW YORK, June 8, 2021 /PRNewswire-PRWeb/ -- The International Trademark Association (INTA) today released an updated version of its best practices document to help brand owners, online marketplaces, and other relevant stakeholders combat counterfeiting on the Internet.

Key Points: 
  • NEW YORK, June 8, 2021 /PRNewswire-PRWeb/ -- The International Trademark Association (INTA) today released an updated version of its best practices document to help brand owners, online marketplaces, and other relevant stakeholders combat counterfeiting on the Internet.
  • The guide's proactive voluntary measures are intended to further safeguard the public from the harms of counterfeiting and provide additional trademark protection to brand owners.
  • A task force of members from INTA's Anticounterfeiting Committee, Enforcement Committee, and Internet Committee prepared the updated guide.
  • The International Trademark Association (INTA) is a global association of brand owners and professionals dedicated to supporting trademarks and related intellectual property (IP) to foster consumer trust, economic growth, and innovation.

Evoke Pharma Announces FDA Orange Book Listing of U.S. Patent for Gimoti®

Retrieved on: 
Tuesday, June 8, 2021
Intellectual property law, Approved Drug Products with Therapeutic Equivalence Evaluations, Food and Drug Administration, Intellectual property organizations, Orange Book, Patent, United States patent law, United States Patent and Trademark Office

11,020,361 for Gimoti (metoclopramide) nasal spray is now listed in the U.S. Food and Drug Administration (FDA) publication, Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book.

Key Points: 
  • 11,020,361 for Gimoti (metoclopramide) nasal spray is now listed in the U.S. Food and Drug Administration (FDA) publication, Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book.
  • As previously announced on June 2, 2021, the United States Patent and Trademark Office (USPTO) issued US patent No.
  • This new patent is now listed in the FDAs Orange Book and carries a patent term to at least 2029.
  • We are pleased to expand and strengthen our intellectual property protection for Gimoti through the listing of our latest patent in the FDAs Orange Book, commented David Gonyer, President and Chief Executive Officer of Evoke Pharma.

IACC Secures Seat at the HSI-Led National Intellectual Property Rights Coordination Center in Historic Step towards Public-Private Partnership

Retrieved on: 
Thursday, June 3, 2021
Intellectual property organizations, National Intellectual Property Rights Coordination Center, U.S. Immigration and Customs Enforcement, Intellectual property, IPR

WASHINGTON, June 3, 2021 /PRNewswire/ -- Today, the National Intellectual Property Rights Coordination Center (IPR Center) and the International AntiCounterfeiting Coalition (IACC) announced that the IACC will havestaff/personnel/employees co-located at the IPR Center's headquarters in Arlington, Virginiato support joint training and operational efforts.

Key Points: 
  • WASHINGTON, June 3, 2021 /PRNewswire/ -- Today, the National Intellectual Property Rights Coordination Center (IPR Center) and the International AntiCounterfeiting Coalition (IACC) announced that the IACC will havestaff/personnel/employees co-located at the IPR Center's headquarters in Arlington, Virginiato support joint training and operational efforts.
  • The significance of having a seat at one of the most prominent government agencies for IP enforcement cannot be overstated," said IACC President Bob Barchiesi.
  • The IACC ( www.iacc.org ) is a Washington, DC-based not-for-profit organization representing the interests of companies concerned with trademark counterfeiting and intellectual property theft.
  • The National Intellectual Property Rights Coordination Center, working collaboratively with its public and private sector partners, stands at the forefront of the United States government's response to combatting global intellectual property theft and enforcing intellectual properties rights violations.

Bubblr Is Making All the Right Moves on the Road to Uplisting

Retrieved on: 
Thursday, May 27, 2021
Intellectual property law, Intangible assets, Intellectual property organizations, United States Patent and Trademark Office, United States trademark law, Trademark, Patent

Bubblr ( BBLR ), an ethical technology company committed to changing the internet for the better, is one of those companies.

Key Points: 
  • Bubblr ( BBLR ), an ethical technology company committed to changing the internet for the better, is one of those companies.
  • On April 13, 2021, the U.S. Patent and Trademark Office approved a Bubblr patent application titled "Internet-Based Search Mechanism."
  • Bubblr has developed an internet that can be used anonymously with no personal tracking or data harvesting.
  • "We are proud to welcome Cecil to our growing Bubblr Advisory Board," said Bubblr CEO Steven Saunders.

Founders Legal® Law Firm Advocates for IP Rights at USPTO Examiner Training

Retrieved on: 
Thursday, May 13, 2021
Intellectual property law, Intellectual property organizations, Legal professions, Patent examiner, United States Patent and Trademark Office, Patent, Software as a service

b'ATLANTA, May 13, 2021 /PRNewswire/ -- Corporate & intellectual property law firm, Founders Legal was invited to speak on behalf of technology entrepreneurs and innovators at the United States Patent and Trademark Office\'s (USPTO) annual Patent Examiner Technical Training Program (PETTP).

Key Points: 
  • b'ATLANTA, May 13, 2021 /PRNewswire/ -- Corporate & intellectual property law firm, Founders Legal was invited to speak on behalf of technology entrepreneurs and innovators at the United States Patent and Trademark Office\'s (USPTO) annual Patent Examiner Technical Training Program (PETTP).
  • Organizers asked the boutique firm and their client, Doug Pittman, CEO of BoardActive Corp., to present their experiences and perspectives on the patent system.\nBoutique law firm, Founders Legal was invited to speak on behalf of technology entrepreneurs at annual USPTO event.\nThe annual PETTP program invites guest lecturers to provide training and industry expertise to over 3,900 USPTO patent examiners regarding recent technological developments.
  • Guest lecturers are required to have relevant technical knowledge and industry experience in the state of the art to which they provide training on.
  • The firm offers a specialized focus on businesses providing software-as-a-service (Saas), enterprise software, advanced technologies, and information technologies (IT).

Exacta Awarded Historic Horse Racing Patent On Using Multiple Past Events To Generate A Wagering Outcome

Retrieved on: 
Tuesday, May 11, 2021
Intellectual property law, Patent offices, Intellectual property organizations, Monopoly, Patent, United States Patent and Trademark Office

b'BOYNTON BEACH, Fla., May 11, 2021 /PRNewswire/ --Exacta Systems announced today that it has been awarded a patent on its techniques for using multiple events that occurred in the past to generate a wagering outcome.

Key Points: 
  • b'BOYNTON BEACH, Fla., May 11, 2021 /PRNewswire/ --Exacta Systems announced today that it has been awarded a patent on its techniques for using multiple events that occurred in the past to generate a wagering outcome.
  • The United States Patent and Trademark Office issued the patent to Exacta for its "System and Method of Wagering on a Plurality of Events" on May 4, 2021.\n"We are very excited that the U.S. Patent Office has granted our patent on using a plurality of events to generate a wagering outcome," commented Exacta Systems CEO Jeremy Stein.
  • "Our innovation opened up the possibilities to create fun, engaging, and competitive products for the historical horse racing industry.
  • We are proud that our innovation encompasses the way historical horse racing systems currently operate.

Palatin Announces U.S. Patent Term Extension for Vyleesi® (bremelanotide injection)

Retrieved on: 
Tuesday, May 4, 2021
Intellectual property law, Patent law, Term of patent in the United States, United States patent law, Intellectual property organizations, Term of patent, International Searching and Preliminary Examining Authorities, Patent offices, Bremelanotide, Drug Price Competition and Patent Term Restoration Act, United States Patent and Trademark Office, Patent

For more information on Vyleesi, go to www.vyleesi.com .\nThe patent term extension is pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984, commonly called the Hatch-Waxman Amendments, which permits an extension of the term of one patent for a maximum period of five years as compensation for patent term lost during drug development and the FDA regulatory review process.

Key Points: 
  • For more information on Vyleesi, go to www.vyleesi.com .\nThe patent term extension is pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984, commonly called the Hatch-Waxman Amendments, which permits an extension of the term of one patent for a maximum period of five years as compensation for patent term lost during drug development and the FDA regulatory review process.
  • An interim extension for a period of one year from the original expiration date of both patents of June 25, 2020, was granted by the USPTO in May 2020.
  • In the Notices of Final Determination issued by the USPTO, the maximum allowable five-year extension was granted.\nPalatin has filed an Election to extend the patent term of U.S. patent 6,794,489.
  • Palatin is not responsible for updating for events that occur after the date of this press release.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/palatin-announces-us-patent-term...\n'

Kaarta Expands Patent Portfolio with Issuance of Another U.S. Patent

Retrieved on: 
Wednesday, April 28, 2021
Intellectual property law, Intellectual property organizations, Bamana, French West Africa, Kaarta, Cision, United States Patent and Trademark Office

b'PITTSBURGH, April 28, 2021 /PRNewswire-PRWeb/ --Kaarta, the innovator of real-time mobile 3D reality capture, announced today that U.S. Pat.

Key Points: 
  • b'PITTSBURGH, April 28, 2021 /PRNewswire-PRWeb/ --Kaarta, the innovator of real-time mobile 3D reality capture, announced today that U.S. Pat.
  • 10,989,542 was issued on April 27, 2021 by the U.S. Patent and Trademark Office.
  • "Knowing the location and pose of sensed data provides great value to a map," said Kevin Dowling, Kaarta CEO.
  • "\nKaarta\'s core technology, Kaarta Engine, was designed from the onset to allow for integration with other systems and sensors.

Magnifact announces issuance of a new U.S. Patent for its AgentVizion Platform

Retrieved on: 
Tuesday, April 27, 2021
Intellectual property law, Intellectual property organizations, Monopoly, Patent, Insurance, United States Patent and Trademark Office

b'CHICAGO, April 27, 2021 /PRNewswire/ -- Leading Chicago-based insurance technology firmMagnifact today announced that the United States Patent and Trademark Office has issued U.S. Patent No.

Key Points: 
  • b'CHICAGO, April 27, 2021 /PRNewswire/ -- Leading Chicago-based insurance technology firmMagnifact today announced that the United States Patent and Trademark Office has issued U.S. Patent No.
  • "This is a key milestone in our product roadmap considering it has taken us six years to build out our platform.
  • We are very excited to continue offering our unique and irreproducible technology to existing and new clients, giving them a distinct, sustainable competitive advantage.
  • For more details, visit https://www.magnifact.com .\nAgentVizion is a secure platform that allows insurance carriers, agencies, and their downline agents to accurately measure their distributionacross different product lines.

Aquavit Wins a Trademark Case over AQUAGOLD in European Union Intellectual Property Office Against a Counterfeiter

Retrieved on: 
Thursday, April 15, 2021
European Union trademark law, Intellectual property law, Brand management, Product management, Intellectual property organizations, Trademark, Marketing, European Union trade mark, European Union Intellectual Property Office, Aquavit, European Union

b'NEW YORK, April 15, 2021 /PRNewswire/ --The European Union Intellectual Property Office (EUIPO) declared that U-BioMed\'s falsely registered AQUAGOLD European Union trademark (No.

Key Points: 
  • b'NEW YORK, April 15, 2021 /PRNewswire/ --The European Union Intellectual Property Office (EUIPO) declared that U-BioMed\'s falsely registered AQUAGOLD European Union trademark (No.
  • 17902149) is invalid in its entirety, as it was originally created and owned by Aquavit Pharmaceuticals, Inc. ("Aquavit").
  • The division concluded that "the [Aquavit\'s] application was totally successful and U-BioMed\'s European Union trademark has been declared invalid for all the contested goods.
  • "\nAquavit\'s microchannel technology, AQUAGOLD, was launched in 2014 at the American Academy of Dermatology, the largest dermatology conference in the world.